AmbioPharm

AmbioPharm, Inc. (APi) has developed a new business model to respond to the accelerating trends in our industry and reduce the cost of manufacturing peptides. We look forward to becoming your manufacturing partner for peptide projects from preclinical, clinical to commercial stages. Allow us to introduce APi's capabilities. A new custom peptide supply service has been established, aimed at rapidly manufacturing peptides for pharmaceutical and biotechnology companies at the lowest cost. According to your requirements, we will provide research-grade peptides for your preclinical in vitro drug and toxicology programs. This service will offer you milligram quantities of research-grade peptides, which are fully qualified and released by our internal quality control department.